Mallinckrodt to Present at Jefferies London Healthcare Conference

STAINES-UPON-THAMES, United Kingdom, Nov. 8, 2019 /PRNewswire/ — Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, will present at the Jefferies London Healthcare Conference in London on Wednesday, Nov. 20, 2019. Bryan Reasons, Executive Vice President and Chief Financial…

About the Author

has written 41769 stories on this site.

Copyright © 2010 Business and Corporate News.